Not all individuals with CLL have to have therapy. Regardless of all new developments, the iwCLL however recommends watchful observation for individuals with asymptomatic disorder.86 This recommendation is based on no less than two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and ritux